Synchronicity Pharma is a biotech company focused on transformative therapies designed to leverage circadian rhythm biology. The company developed the first-ever clinical-stage compound shown to safely target the core-clock molecular machinery and to modulate clock-regulated gene expression in humans.
Synchronicity Pharma was founded in 2008 and is based in San Jose, California.